{"id":66404,"date":"2026-07-06T15:33:13","date_gmt":"2026-07-06T15:33:13","guid":{"rendered":"https:\/\/www.elixirr.com\/en-gb\/?p=66404"},"modified":"2026-07-06T15:33:15","modified_gmt":"2026-07-06T15:33:15","slug":"the-rise-of-glp-1-drugs-why-the-beverage-industrys-biggest-challenge-isnt-reformulation-its-relevance","status":"publish","type":"post","link":"https:\/\/www.elixirr.com\/en-gb\/the-rise-of-glp-1-drugs-why-the-beverage-industrys-biggest-challenge-isnt-reformulation-its-relevance\/","title":{"rendered":"The rise of GLP-1 drugs: Why the beverage industry\u2019s biggest challenge isn\u2019t reformulation \u2013 it\u2019s relevance"},"content":{"rendered":"\n
\n
\n

Over the past decade, the beverage aisle has been reshaped by health-driven reformulation. What started as niche preferences \u2013 low-fat, low-alcohol,\u00a0zero-sugar, gut-friendly \u2013 evolved into mainstream expectations, pushing brands to diversify,\u00a0premiumise\u00a0and reformulate. Health shifted from a sub-category to centre-stage.<\/span>\u00a0<\/span><\/p>\n

However,\u00a0the rise of GLP-1 weight-loss drugs marks a fundamentally different inflection point.<\/span>\u00a0<\/span><\/p>\n

Unlike\u00a0previous\u00a0health trends that encouraged consumers to make\u00a0\u2018better\u2019\u00a0choices, GLP-1 medications reduce appetite itself. They do not simply steer shoppers toward lower-calorie drinks \u2013 they suppress the very impulse to consume. This is not a reformulation challenge. It is a demand challenge.<\/span>\u00a0<\/span><\/p>\n

By the end of 2024, the US GLP-1 market reached approximately\u00a0$50 billion and is forecast to double by the end of the decade.<\/span><\/a>\u00a0The downstream implications for food and drink are already material.\u00a0<\/span>By 2030, it is estimated that 35% of food and beverage sales could be influenced by GLP-1 users.<\/span><\/a>\u00a0<\/span>In the US, around 1 in 8 adults report having taken weight-loss medication in the past year.<\/span><\/a>\u00a0<\/span>While UK\u00a0uptake\u00a0remains lower at approximately 2.9%,<\/span><\/a>\u00a0penetration\u00a0is rising rapidly as access improves and social normalisation\u00a0increases. As with most transformative health movements, adoption is unlikely to remain geographically\u00a0contained.<\/span>\u00a0<\/span><\/p>\n

This raises an uncomfortable\u00a0question for an industry built on frequency,\u00a0occasion\u00a0and impulse: what happens when appetite declines at scale?<\/span>\u00a0<\/span><\/p>\n

For beverage brands, the strategic challenge extends far beyond\u00a0\u2018healthier\u2019\u00a0formulations. The real question is how to drive growth when consumption occasions shrink, when habitual purchases soften and when consumers\u00a0don\u2019t\u00a0just want fewer calories \u2013 they want fewer drinks.<\/span>\u00a0<\/span><\/p>\n

GLP-1s signal not\u00a0just\u00a0a behavioural shift, but a psychological one. Hunger cues change, impulse purchases decline\u00a0and social and habitual drinking occasions evolve. The impact reaches beyond\u00a0portion\u00a0size to fundamentally reshape how,\u00a0when\u00a0and why people drink at all.<\/span>\u00a0<\/span><\/p>\n

In recent conversations with our\u00a0partners at\u00a0<\/span>Pilot Lite<\/span><\/a>, one point came through clearly: many CPG organisations understand the headline risk, but\u00a0far fewer have changed the\u00a0operating rhythm\u00a0in response.\u00a0In an increasingly complex and changing market, the advantage\u00a0is not simply a strong\u00a0strategy, but\u00a0rather\u00a0being\u00a0able to\u00a0learn fast\u00a0and reduce the\u00a0timeframe\u00a0between consumer insight, decision-making, supply\u00a0planning\u00a0and in-market\u00a0execution. The brands that win will not be those that resist these shifts or\u00a0attempt\u00a0incremental reformulation. They will be those that understand the behavioural\u00a0mechanics underpinning it \u2013 and build the organisational and supply chain muscle to act on them.<\/span>\u00a0<\/span><\/p>\n

So, what do we already know about these changing consumer behaviours? And more importantly, what must brands do now to stay ahead?<\/span>\u00a0<\/span><\/p>\n

Insight\u00a0one:\u00a0From impulse consumption to intentional drinking<\/h2>\n

GLP-1 drugs have a far greater impact than\u00a0simply\u00a0suppressing appetites \u2013 they reshape consumer psychology.\u00a0<\/span>Consumption is shifting from reactive and impulse-led to deliberate and goal-oriented.<\/span>\u00a0<\/span><\/p>\n

GLP-1 users consistently report a decline in\u00a0\u2018grab it because it\u2019s there\u2019\u00a0behaviour. Beverage purchases become more purposeful: hydration, protein intake, digestive support, lower sugar, lower alcohol\u00a0etc. Alcohol offers a clear example.\u00a0<\/span>Clinical research indicates GLP-1 users reduce alcohol consumption by roughly 30\u201340%<\/span><\/a>. As\u00a0<\/span>GLP-1 adoption rises,\u00a0this behavioural moderation\u00a0represents\u00a0a structural risk to the alcohol sector;\u00a0<\/span>in markets such as the UK, some beer and spirits brands are already reporting early signs of impact.<\/span><\/a>\u00a0<\/span><\/p>\n

Broader spending data\u00a0also\u00a0reflects this moderation.\u00a0<\/span>Research from Cornell University in 2024 found spending on coffee and fast-food beverages declined by approximately 8% among GLP-1 households<\/span><\/a>. This is not category abandonment\u00a0\u2013 it\u00a0is behavioural\u00a0change.<\/span>\u00a0<\/span><\/p>\n

The shift has a biological basis. GLP-1 medications act on brain regions linked to reward processing and impulse control, dampening cravings and reducing the pull of instant gratification. The result is not just smaller baskets, but more intentional ones.<\/span>\u00a0<\/span><\/p>\n

GLP-1 users are redefining the\u00a0purpose of beverages. Consumption must increasingly justify itself\u00a0as functional fuel, not just taste,\u00a0treat\u00a0or habit.<\/span>\u00a0<\/span><\/p>\n

In conversations with Pilot Lite, they pointed to\u00a0Huel as a brand that\u00a0benefits\u00a0from a GLP-1-era logic: consumers may not feel like eating, but they still need nutrients. Danone\u2019s recent\u00a0agreement to\u00a0acquire\u00a0Huel, extending its portfolio into functional nutrition, suggests that large corporations are beginning to value brands built around convenience, nutrient\u00a0density\u00a0and complete fuelling, rather than traditional taste and enjoyment alone.\u00a0<\/span>\u00a0<\/span><\/p>\n

This does not mean taste and pleasure disappear, but they do become less decisive.\u00a0Early evidence has suggested that GLP-1 usage can even alter taste preferences\u00a0\u2013 in some cases\u00a0permanently.\u00a0If\u00a0appetite and cravings are muted, the old hierarchy of flavour-first indulgence weakens.\u00a0<\/span>\u00a0<\/span><\/p>\n

Insight\u00a0two: From brand loyalty to trust<\/h2>\n

As behaviour becomes more intentional, brand relationships evolve.<\/span>\u00a0<\/span><\/p>\n

GLP-1 users are paying closer attention to what is inside their drinks: sugar load, protein levels, alcohol strength, artificial ingredients,\u00a0carbonation\u00a0and acidity. This is not simply heightened health-consciousness\u00a0\u2013 it is\u00a0a form of\u00a0risk management.\u00a0<\/span>GLP-1 medications are associated with side effects including nausea, bloating, reflux, constipation and gastrointestinal discomfort \u2013 with around 40% of users reporting some form of adverse effect<\/span><\/a>.\u00a0GLP-1 users are increasingly conscious that consumption carries consequence.<\/span>\u00a0<\/span><\/p>\n

The decision framework shifts from\u00a0\u2018I like this brand\u2019\u00a0to\u00a0\u2018can I rely on this brand not to make me feel unwell?\u2019<\/span>\u00a0<\/span><\/p>\n

Research supports this more evaluative mindset.\u00a0<\/span>A 2025 study by Acosta Group found nearly 80% of GLP-1 users conduct product and health research to support their weight-loss journey, with 36% consulting a nutritionist<\/span><\/a>. These consumers are actively interrogating ingredients\u00a0and functional claims rather than defaulting to habitual favourites.<\/span>\u00a0<\/span><\/p>\n

In this environment, reassurance overtakes recognition.\u00a0Brand loyalty is not dead, but it manifests\u00a0differently: consumers are\u00a0more fickle, more informed and quicker to switch when a brand no longer feels\u00a0culturally or physically compatible.\u00a0Ingredient transparency, digestive\u00a0tolerance\u00a0and functional alignment matter more than heritage branding. Trust\u00a0\u2013 defined\u00a0by clarity,\u00a0simplicity\u00a0and credibility\u00a0\u2013 becomes the new competitive advantage.<\/span>\u00a0<\/span><\/p>\n

Insight\u00a0three:\u00a0Retail economics\u00a0shift<\/h2>\n

The third shift is structural.<\/span>\u00a0<\/span><\/p>\n

GLP-1 medications dampen dopamine signalling in the brain\u2019s reward pathways.<\/span><\/a>\u00a0Consumers do not just consume less\u00a0\u2013 they\u00a0want less. This directly challenges the commercial architecture of beverage retail.<\/span>\u00a0<\/span><\/p>\n

Volume-led growth models assume appetite elasticity\u00a0\u2013 that\u00a0shoppers can be nudged into buying more than planned. Multi-buy promotions, upsizing, end-of-aisle\u00a0displays\u00a0and checkout fridges are all designed to stimulate incremental desire.<\/span>\u00a0<\/span><\/p>\n

But when appetite capacity declines and dopamine response is blunted, that elasticity weakens.\u00a0\u2018Buy-one-get-one-free\u2019\u00a0offers lose power when a second unit feels excessive. High-impact displays generate visibility, but not urgency. The financial modelling that underpins bundling and promotional depth becomes harder to sustain.<\/span>\u00a0<\/span><\/p>\n

GLP-1 drugs do not merely trim demand at the margins\u00a0\u2013 they\u00a0erode the behavioural economics that have supported decades of impulse-driven volume growth. In a lower-reward, lower-frequency environment, brands must compete on relevance,\u00a0context\u00a0and function rather than engineered excitement.<\/span>\u00a0<\/span><\/p>\n

Insight\u00a0four:\u00a0The power of supply chains<\/h2>\n

The fourth shift is operational: supply chain\u00a0agility\u00a0becomes\u00a0a competitive advantage. Changes in consumption \u2013 from smaller portions\u00a0and product formulations\u00a0\u2013 require\u00a0rapid shifts in manufacturing,\u00a0packaging\u00a0and distribution.<\/span>\u00a0<\/span><\/p>\n

As Pilot Lite\u00a0shared, many large organisations do not have the\u00a0flexibility\u00a0and agility to\u00a0test new products,\u00a0quickly\u00a0access alternative\u00a0manufacturing\u00a0and\u00a0adjust\u00a0based on\u00a0ever-changing consumer preferences.\u00a0The implication is not just to rethink growth models, but a need to rethink the speed at which those models can be tested and adapted\u00a0\u2013 and whether the infrastructure, governance and partner ecosystem exist to support them.<\/span>\u00a0<\/span><\/p>\n

This is where the speed of translating insight into\u00a0decisions becomes critical. In the old model, consumer insights, marketing,\u00a0sales\u00a0and demand planning could cooperate sequentially. In the current environment, they need to\u00a0operate\u00a0as an integrated system: spotting demand shifts, making decisions, testing in-market and adapting supply in a much tighter loop.\u00a0<\/span>\u00a0<\/span><\/p>\n

 <\/p>\n

So what? Three strategic recommendations for beverage brands<\/h2>\n

If GLP-1 rewires consumption logic, brands must respond on\u00a0three\u00a0fronts: economics,\u00a0credibility\u00a0and\u00a0context,\u00a0all whilst ensuring\u00a0a timely\u00a0operating\u00a0speed.\u00a0<\/span>\u00a0<\/span><\/p>\n

1. Rebuild the growth model beyond volume<\/h3>\n

GLP-1 drugs\u00a0undermine the assumption\u00a0of appetite elasticity, resulting in fewer impulse\u00a0purchases, less incremental\u00a0units\u00a0and lower\u00a0tolerance for excess.<\/span>\u00a0<\/span><\/p>\n

For decades beverage growth has relied on frequency expansion, upsizing,\u00a0bundling\u00a0and multi-pack promotions.\u00a0In this way, the model relied upon being able to persuade consumers in the moment. As consumption becomes increasingly intentional and frequency declines, this growth equation changes\u00a0from volume per basket to probability of being in the basket.<\/span>\u00a0<\/span><\/p>\n

The strategy now shifts from\u00a0selling more product, to securing inclusion\u00a0in shrinking\u00a0baskets.\u00a0<\/span>\u00a0<\/span><\/p>\n

Beverage brands should conduct a portfolio audit through an economic lens\u00a0to ensure margin\u00a0resilience without a dependency on volume.\u00a0This is not simply\u00a0rationalisation\u00a0for its own sake: it is about\u00a0identifying\u00a0where to place fewer, bigger bets in a market where SKUs\u00a0consume organisational energy.\u00a0As demand for more\u00a0units\u00a0declines, brands need to ask:<\/span>\u00a0<\/span><\/p>\n